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Intensivists' opinion and self-reported practice of oxygen therapy G. M. EASTWOOD*, M. C. READE †, L. PECK ‡, D. JONES §, R. BELLOMO** Intensive Care Unit, Austin Hospital, Heidelberg, Victoria, Australia SUMMARY Intensivists frequently prescribe oxygen therapy for critically ill patients, however little is known about how intensivists manage oxygen therapy, or what factors influence their decisions. We surveyed intensivists listed on the Australian and New Zealand Intensive Care Society Clinical Trials Group database to investigate how intensivists report their approach to the monitoring, prescription and management of risks associated with oxygen therapy. The response rate was 60.4% (99/164 intensivists). Overall 81 (83.5%) respondents practised in metropolitan units and 50 (50.5%) had ≥14 years of intensive care unit specialty practice. All respondents reported using pulse oximetry and >93% reported having access to a blood gas machine within their intensive care unit. Sixty-one percent of respondents (60/98) reported assessing other indices of tissue oxygenation (pH, lactate, MvO 2 ). Twelve respondents (12. 8%) believed that oxygen toxicity was a greater threat to lung injury than barotrauma when commencing mechanical ventilation. A significantly (P=0.016) greater proportion of regional (5/16) than metropolitan (7/70) respondents were concerned that a high FiO 2 is a greater threat to the lungs than barotrauma. For a ventilated acute respiratory distress syndrome patient, 36.8% (36/98 respondents) would not allow an S a O 2 of <85% for ≤15 minutes, and 27.6% (27/96 respondents) would not allow an S a O 2 <90% for >24 hours. Respondents with ≤14 years of specialty practice were more likely to specify the oxygen delivery device to be used (P=0.014). Recognising the factors that currently influence oxygen administration decisions is a necessary prelude to the potential conduct of interventional studies, as well as for the development of better guidance for oxygen therapy in critical care.
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Development and piloting of the questionnaire
We used an anonymous structured multichoice questionnaire to survey intensivists. The questionnaire consisted of 12 questions in three parts. The questionnaire was modified from an earlier eight-question structured postal questionnaire of Canadian ICU medical directors that sought to elicit attitudes on oxygen use for patients receiving mechanical ventilation 3 . Our questionnaire was pilot tested amongst eight intensivists at one tertiary teaching hospital and revised prior to use.
Target population, recruitment and administration of the questionnaire
The target population for the survey consisted of intensivists working in Australian and New Zealand intensive care units. Intensivists were identified using the Australian and New Zealand Intensive Care Society Clinical Trials Group database. Each intensivist was invited by email to respond to the questions on an online survey site. A single reminder email was sent six weeks later. Responses were recorded during an eight-week period from August to October 2009.
Data management and analysis
All responses are expressed as a percentage of the total number of responses for each particular question. No imputation has been made as the proportion of missing values was so low: all questions had five or less (≤5%) missing responses. Statistical analysis was performed using STATA 9.2 (StataCorp, College Station, TX, USA), with differences between groups assessed using chi-squared tests and multivariable and multinomial logistic regression as appropriate.
RESULTS

Characteristics of cohort
Survey invitations were emailed to 164 intensivists. Ninety-nine full or partial responses were received (60.4%), with full responses received from 90 intensivists (54.9%). Eighty-one (83.5%) respondents practised in metropolitan ICUs, and 48 (49%) had been in specialty practice for ≤14 years. There was a trend for intensivists with fewer (≤14) years of special practice to be located in regional areas (11/47 vs 5/50, P=0.075). The demographic characteristics of respondents are shown in Table 1 .
Monitoring of oxygenation
All respondents used pulse oximetry and nearly all respondents (92/98) reported having access to a blood gas analysis machine within their ICU. In response to hypoxia despite a high FiO 2 , 60 of 98 respondents (61.2%) reported using other indices (blood lactate, mixed venous oxygen saturation and pH) as surrogates for this variable in the presence of hypoxia. Major concern 26 (26.5%)
Concern, but not major 57 (58.2%)
Not a concern 15 (15.3%)
"Which of the following poses a greater threat of lung injury during mechanical ventilation?" (94 responses) 
Response differences depending on duration of practice
A significantly (P=0.016) greater proportion of regional (5/16) than metropolitan (7/70) intensivists were concerned that a high FiO 2 is a greater threat to the lungs than barotrauma. Compared to intensivists who had more than 14 years of speciality practice, intensivists with fewer than 14 years of practice more frequently answered 'yes, always' when asked whether they would measure indices of tissue oxygenation such as blood lactate, mixed venous oxygen saturation and pH (22/50 vs 38/48, P=0.002). Multivariable analysis examining location and duration of practice as independent predictors of answers to all questions confirmed these univariate trends, and additionally, intensivists with fewer than 14 years of specialty practice more often reported specifying the oxygen delivery device "100% of the time" (P=0.014).
DISCUSSION
Summary of major findings
Our study has four key findings. First, respondents varied in their tolerance for hypoxaemia in a ventilated ARDS patient. Second, more than 10% of respondents believed that oxygen toxicity was a greater threat to lung injury than barotrauma when commencing mechanical ventilation. Third, more than a third of respondents reported not always using other indices (blood lactate, mixed venous oxygen saturation or pH) to assess tissue oxygenation. Finally, location of practice (rural vs metropolitan) and time since specialisation influenced attitudes regarding oxygen toxicity and the use of indices of oxygenation.
Strengths and weakness
Our study has several strengths. It was based on a previously used study and piloted amongst intensivists 5 . The response rate was >60% despite being an online survey, thereby limiting the impact of non-response bias 6 . To our knowledge, this is the largest sample of Australian and New Zealand intensivists surveyed in relation to oxygen therapy practices reported to date. Conversely, the study has some limitations. First, although we had a high response rate from the Australian and New Zealand Intensive Care Society Clinical Trials Group intensivists, differences between respondents and non-respondents may exist. Second, responses were self-reported data and, as such, may not reflect actual practice. However, there is evidence that the process of observation alters clinical behaviour 7, 8 , implying our approach is not necessarily inferior to direct observation. Third, the clinical scenarios may not have provided enough information on which to make a clinical judgment. Finally, the observed associations between answer patterns and location and duration of practice do not necessarily imply causality 6 .
Comparison with previous studies One previous study directly evaluated how intensivists manage oxygen therapy for critically ill patients. In 1999, Mao et al 3 , in their postal questionnaire of 52 directors of Canadian medical ICUs, identified considerable variation in the attitudes, beliefs and stated practices in relation to the management of oxygen therapy. Key findings from this Canadian study were a tendency amongst intensivists to target and alter fraction of inspired oxygen (FiO 2 ) and variability between intensivists' stated tolerance to degrees and duration of oxygen exposure. Our study identified similar heterogeneity in practice. For example, a similar proportion of respondents identified oxygen toxicity as a threat to lung injury for the mechanically ventilated patient, Australian and New Zealand respondents 12.8% vs Canadian respondents 13%. However, a higher proportion of Canadian respondents (71%) reported they would assess indices of tissue oxygenation compared to Australian and New Zealand respondents (61%). In 2008, the British Thoracic Society published a guideline for the emergency use of oxygen in adult patients 2 . This guideline recommends target blood oxygen saturations (SpO 2 ) of 94 to 98% for most acutely ill patients or 88 to 92% for patients at risk of hypercapnoeic respiratory failure. Evidence supporting these recommendations is lacking, and the guidelines do not apply to mechanically ventilated patients. The variation between intensivists that we observed is therefore not surprising, as evidence or consensus guidance on the use of oxygen therapy in the care of the critically ill is largely absent from the literature.
Tolerance for lower arterial oxygen tensions in the management of ARDS has often been a trade-off between providing prolonged high inspired oxygen concentrations, optimising tissue oxygenation and avoiding the pathophysiological consequences of traditional approaches to mechanical ventilation. Damage to the lungs associated with mechanical ventilation may be exacerbated by prolonged high inspired oxygen concentrations but the evidence for oxygen toxicity in man is less well established than in animals [9] [10] [11] [12] [13] . In the management of severe ARDS, clinicians often exercise a tolerance for hypoxaemia 14 in situations where oxygen delivery (cardiac output and haemoglobin concentrations) can be optimised as a strategy to limit lung injury. There is no evidence in man that oxygen is less injurious to the lungs than barotrauma or volutrauma. Almost all respondents were more concerned about barotrauma, with only 12.8% indicating that oxygen toxicity was of a greater risk when commencing mechanical ventilation. This finding may be more reflective of the threat of lung damage associated with the 'duration' or mechanical ventilation as opposed to that at the time of 'commencement' of mechanical ventilation.
More than a third of respondents surveyed reported not always using indices such as lactate or mixed venous oxygen saturation. Recognising tissue hypoxia in the setting of critical illness is complicated, as many mechanisms may contribute to inadequate tissue oxygenation (e.g. arterial hypoxaemia, lowcardiac output and inadequate oxygen extraction) 15, 16 . Plausibly, all intensivists would consider arterial pH and lactate as markers of tissue oxygenation as these values are routinely repeated as a part of arterial blood gas measurements. Whether intensivists view current markers (pH, lactate, and mixed venous oxygen saturation) or novel markers (e.g. gastric tonometry, pHi) or near infrared spectroscopy for tissue oxygen saturation) [17] [18] [19] as being valuable in guiding their oxygen administration decisions remains unclear 20, 21 . Lack of consensus about the usefulness of these markers may be responsible for the variability in their use. In response, careful examination of patient outcomes associated with the monitoring and treatment of tissue hypoxia based on available markers will need to be explored.
Our study also examined the effect of location of practice and time since specialisation on intensivists' opinion of oxygen therapy. Our findings identified greater proportion of regional intensivists were concerned that a high FiO 2 is a greater threat to the lungs than barotrauma than were metropolitan intensivists. Intensivists with fewer than 14 years of practice more frequently answered 'yes, always' in response to measuring indices of tissue oxygenation (blood lactate, mixed venous oxygen saturation) and more often reported specifying the oxygen delivery device "100% of the time". Because there are no data on the types of influences responsible for the identified differences between metropolitan and rural intensivists, further exploration of the contextual factors that impact on intensivists' oxygen administration decisions, for example exposure to ventilated ARDS patients, availability of oxygen delivery devices or the availability of tissue oxygenation monitoring devices, is warranted.
Clinical implications
While the aim of this study was not to investigate how intensivists make oxygen administration decisions, the proportion of intensivists who differed in their responses to assessing tissue oxygen or managing risks associated with oxygen delivery suggests there are many different beliefs. Variability in oxygen therapy practice amongst intensivists is likely to continue until there is evidence from clinical trials to support clinical practice guidelines. Such trials could address questions like "what is a safe P a O 2 for a prolonged period?", "can the P a O 2 be maintained at a lower than conventionally safe level if the surrogate indices of tissue oxygenation are reassuring?", "which is more detrimental -high mean airway pressure or high FiO 2 ?", and "does this differ according to lung pathology?"
In conclusion, we found intensivists varied in their prescribing and attitudes of risks associated with oxygen therapy for critically ill patients. There is a need to further explore the factors that currently influence clinical decisions as a necessary prelude to the potential conduct of interventional studies and the development of better guidance for oxygen therapy in critical care.
